IDEXX Laboratories, Inc. (IDXX)

IDEXX Laboratories Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	453.93	112.55	144.45	383.93	90.33
Cash & Cash Equivalents	453.93	112.55	144.45	383.93	90.33
Cash Growth	303.33%	-22.09%	-62.37%	325.05%	-27.04%
Receivables	457.45	400.62	368.35	331.43	269.31
Inventory	380.28	367.82	269.03	209.87	195.02
Other Current Assets	203.6	220.49	173.82	137.51	124.98
Total Current Assets	1,495	1,101	955.66	1,063	679.64
Property, Plant & Equipment	817.68	768.09	692.77	646.34	614.45
Goodwill and Intangibles	450.46	459.47	458.38	295.89	298.19
Other Long-Term Assets	496.53	417.73	330.4	289.6	240.19
Total Long-Term Assets	1,765	1,645	1,482	1,232	1,153
Total Assets	3,260	2,747	2,437	2,295	1,832
Accounts Payable	110.64	110.22	116.14	74.56	72.17
Deferred Revenue	65.73	68.8	81.21	88.73	90.21
Current Debt	325	653.98	148.5	49.99	288.77
Other Current Liabilities	450.18	402.8	417.74	369.49	274.2
Total Current Liabilities	951.55	1,236	763.58	582.76	725.34
Long-Term Debt	722.55	795.63	862.58	935.53	766.38
Other Long-Term Liabilities	101.29	106.6	121.05	143.47	162.93
Total Long-Term Liabilities	823.85	902.23	983.63	1,079	929.31
Total Liabilities	1,775	2,138	1,747	1,662	1,655
Total Debt	1,048	1,450	1,011	985.52	1,055
Debt Growth	-27.74%	43.37%	2.59%	-6.60%	5.48%
Retained Earnings	4,445	3,600	2,920	2,176	1,596
Comprehensive Income	-71.21	-77.8	-53.48	-53.62	-46.18
Shareholders' Equity	1,485	608.74	689.99	632.09	177.47
Net Cash / Debt	-593.62	-1,337.06	-866.62	-601.59	-964.82
Net Cash Per Share	-7.07	-15.80	-10.01	-6.94	-11.02
Working Capital	543.71	-134.33	192.08	479.98	-45.7
Book Value Per Share	17.87	7.28	8.10	7.41	2.06

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).